Optiver Holding
DAWN

Optiver Holding’s Day One Biopharmaceuticals DAWN Stock Holding History

Optiver Holding’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$686 Sell
32
-260
-89% -$3.66K ﹤0.01% 2121
2025
Q4 		$2.72K Sell
292
-720
-71% -$6.01K ﹤0.01% 1820
2025
Q3 		$7.13K Buy
+1,012
New +$6.96K ﹤0.01% 1503

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Optiver Holding's DAWN Position: Q1 2026 in Review

Optiver Holding reduced its Day One Biopharmaceuticals (DAWN) stake by 89% in Q1 2026, selling an estimated $3.66K and leaving 32 shares worth $686. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Optiver Holding first reported a position in DAWN in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.13K in Q3 2025. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Optiver Holding held 32 shares of Day One Biopharmaceuticals worth $686 as of Q1 2026.
  • Optiver Holding sold 260 Day One Biopharmaceuticals shares in Q1 2026, an estimated $3.66K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2121 holding.
  • Optiver Holding first reported a position in Day One Biopharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Day One Biopharmaceuticals position peaked at $7.13K in Q3 2025.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.